CLAIRYG

Details for Australian Trade Mark No. 1432312 (hide)

Owner LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES

Convention FR 29 March 2011 11 3 818 690

Service Refer to WIPO Address for Correspondence

Filing Date 15 April 2011

Classes

Class 5 Polyvalent human immunoglobulin to be administered parenterally, subcutaneously or intravenously, by health care workers in hospitals and clinics, in outpatient clinics and during external consultations, in medical practices and by self-administration

Event Publications

7 July 2011 Application filed

1 September 2011 Application Accepted

15 December 2011 Trade Mark Registered/Protected

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the ATMOSS Australian Trade Mark On-line Search System.

Next and Previous Trademarks/Applications

1432313-SPAX

1432311-PRIAXOR